Science Explorer Back to mapMap

Most cited papers from PhaseBio Pharmaceuticals (United States)

What are the most cited papers from PhaseBio Pharmaceuticals (United States)?

The most cited paper from PhaseBio Pharmaceuticals (United States) is "Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers" (Deepak L. Bhatt, Charles V. Pollack, Jeffrey Ian Weitz et al., 2019), with 137 citations. Next come "One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer" (129) and "Aldosterone and aldosterone synthase inhibitors in cardiorenal disease" (60).

Showing 15 of 15 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Deepak L. Bhatt, Charles V. Pollack, Jeffrey Ian Weitz et al. · New England Journal of Medicine Open access 17 Mar 2019 137
2 One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer Kelli M. Luginbuhl, Jeffrey L. Schaal, Bret R. Umstead et al. · Nature Biomedical Engineering Open access 5 Jun 2017 129
3 Aldosterone and aldosterone synthase inhibitors in cardiorenal disease Subodh Verma, Avinash Pandey, Arjun K. Pandey et al. · American Journal of Physiology-Heart and Circulatory Physiology 22 Dec 2023 60
4 Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery Deepak L. Bhatt, Charles V. Pollack, C. David Mazer et al. · NEJM Evidence 22 Dec 2021 58
5 The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists Jay M. Matthews, Na Qin, Raymond W. Colburn et al. · Bioorganic & Medicinal Chemistry Letters Open access 27 Feb 2012 37
6 Population pharmacokinetic–pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers Steven J. Kathman, Jeffery J. Wheeler, Deepak L. Bhatt et al. · CPT Pharmacometrics & Systems Pharmacology Open access 29 Oct 2021 11
7 VASOMERA™, A NOVEL VPAC2-SELECTIVE VASOACTIVE INTESTINAL PEPTIDE AGONIST, ENHANCES CONTRACTILITY AND DECREASES MYOCARDIAL DEMAND IN DOGS WITH BOTH NORMAL HEARTS AND WITH PACING-INDUCED DILATED CARDIOMYOPATHY Carlos L. del Rio, Robert J. D. George, Pamela Kloepfer et al. · Journal of the American College of Cardiology Open access Mar 2013 9
8 A safety and pharmacodynamic study of the highly selective aldosterone synthase inhibitor PB6440 in the cynomolgus monkey Bertram Pitt, Deepak L. Bhatt, Robert J. Schotzinger et al. · European Heart Journal Open access Oct 2022 3
9 Evaluation of Vasomera™, a Novel VPAC2-Selective Vasoactive Intestinal Peptide Agonist, in Rats With Doxorubicin-Induced Cardiomyopathy: Evidence for Chronic Cardio-Protection. Bradley L. Youngblood, Steven Yeh, Lynne Georgopoulos et al. · Journal of Cardiac Failure Aug 2012 3
10 Bentracimab demonstrates reversal of antiplatelet effects of ticagrelor: impact of hematocrit and generic versions of ticagrelor in vitro B Curry, R Brown, Deepak L. Bhatt et al. · European Heart Journal Open access Oct 2022 2
11 2350Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452 Lisa K. Jennings, Benjamin J. Curry, Deepak L. Bhatt et al. · European Heart Journal Oct 2019 2
12 Vasomera™, a Novel VPAC2-Selective Vasoactive Intestinal Peptide Agonist, Improves Ventriculo-Arterial Coupling and Decreases Myocardial Demand in Sheep with Induced Ischemic Heart Failure Carlos L del Rio, Bradley L. Youngblood, Robert S. George et al. · Journal of Cardiac Failure Open access Aug 2014 1
13 ENHANCED INHIBITION OF ALDOSTERONE PRODUCTION BY PB6440, A NOVEL AND VERY HIGHLY SELECTIVE ALDOSTERONE SYNTHASE INHIBITOR James Jowett, Bertram Pitt, Robert J. Schotzinger et al. · Journal of the American College of Cardiology Open access Mar 2023 0
14 BLEEDING AND PROCEDURE RATES AMONG PATIENTS TREATED WITH P2Y12 INHIBITORS COMPARED WITH FACTOR XA INHIBITORS: A REAL-WORLD ANALYSIS Amanda M. Kong, John Lee, Kristin A. Evans et al. · Journal of the American College of Cardiology Open access May 2021 0
15 Acute pulmonary artery hypertension in closed-chest anesthetized rats and the sustained pulmonary artery vaso-relaxation following treatment with a novel vasoactive intestinal peptide Brad L. Youngblood, Carlos L del Rio, Steven Yeh et al. · Journal of Pharmacological and Toxicological Methods Jul 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.